Clinical Trials Insight: 700053467

Trial Profile

Clinical Trials Insight: 700053467

Planning
Phase of Trial: Phase II

Latest Information Update: 17 Aug 2010

At a glance

  • Drugs Bremelanotide; Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Aug 2010 In the fourth quarter of 2010, Palatin Technologies expects to meet with the FDA to discuss initiation of this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top